AlphaCentric Advisors’s Quest Diagnostics DGX Stock Holding History

AlphaCentric Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-995	Closed	-$145K	–	233
2021 Q3	$145K	Buy	995 +2	+0.2%	+$293	0.04%	140
2021 Q2	$131K	Buy	993 +129	+15%	+$16.9K	0.04%	152
2021 Q1	$111K	Sell	864 -25	-3%	-$3.08K	0.04%	141
2020 Q4	$106K	Buy	889 +654	+278%	+$79.7K	0.04%	120
2020 Q3	$27K	Sell	235 -75	-24%	-$8.86K	0.01%	132
2020 Q2	$35K	Buy	+310	New	+$32.9K	0.02%	101

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

AlphaCentric Advisors's DGX Position: Q4 2021 in Review

AlphaCentric Advisors sold out of Quest Diagnostics (DGX) in Q4 2021, closing a stake of 995 shares — an estimated $145K sold.

AlphaCentric Advisors first reported a position in DGX in Q2 2020 and held it in 6 quarters. The position peaked at $145K in Q3 2021. 905 funds tracked by Wall St. Rank hold DGX as of Q4 2021.

AlphaCentric Advisors reported no remaining Quest Diagnostics position as of Q4 2021 after selling out during the quarter.
AlphaCentric Advisors sold 995 Quest Diagnostics shares in Q4 2021, an estimated $145K.
AlphaCentric Advisors first reported a position in Quest Diagnostics in Q2 2020 and held it in 6 quarters.
AlphaCentric Advisors's Quest Diagnostics position peaked at $145K in Q3 2021.
905 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2021.

Based on AlphaCentric Advisors's 13F filing for Q4 2021, filed 25 Feb 2022.